Emergency response healthcare startup Wecomet (CEO Lee Jeong-hoon) announced on the 22nd that it has signed a memorandum of understanding (MOU) with the Korea Basketball League (KBL) to provide automated external defibrillators (AEDs) to enhance the safety of professional basketball players and team members.
Under this agreement, Wicomet will supply a total of 22 LIFEPAK CR2 AEDs to the KBL and its 10 affiliated clubs. These devices will be installed at each club's training facility and on team buses, ensuring they are ready for emergencies that may arise during games or while on the move.
Additionally, cardiopulmonary resuscitation (CPR) training will be provided to players and club members. This will enable them to respond immediately in the event of an emergency on-site.
The LifePak CR2 AED utilizes cprINSIGHT technology, enabling real-time electrocardiogram analysis even during CPR. Its intuitive graphics and voice guidance enhance user convenience and accuracy. In particular, the ClearVoice feature automatically adjusts voice volume, ensuring reliable operation even in noisy stadium environments.
Wecomet currently supplies emergency medical equipment to emergency medical centers, fire departments, the Korean Red Cross, university hospitals, educational institutions, and private companies, and has provided training to approximately 25,000 people through safety education programs utilizing the CPR training mannequin 'Brayden'.
A KBL official stated, “Ensuring the safety of both players and fans is the top priority in professional basketball,” and “Through this agreement, we will further strengthen the emergency response system in the stadium and training environment.”
“In emergency situations like cardiac arrest, initial response can determine life,” said Lee Jeong-hoon, CEO of Wicomet. “Through our collaboration with KBL, we will contribute to raising safety awareness in professional sports settings and spreading a safety culture throughout society.”
- See more related articles
You must be logged in to post a comment.